Please login to the form below

Not currently logged in
Email:
Password:

UK knows ‘almost nothing’ about pancreatic cancer

Celgene-sponsored survey shows 64% of people know little about the disease

UK flag 

Nearly two thirds of the UK population is lacking in awareness of pancreatic cancer, according to a new survey sponsored by Celgene.

According to data collected from 7,000 adults in Europe and the US, 64% of people in the UK say they know 'almost nothing' about the disease despite it being the fifth most common cause of death among cancers in the UK.

In response, Celgene said it would be begin a working partnership with pancreatic cancer organisations, such as Pancreatic Cancer UK and Pancreatic Cancer Action, to raise the level of education and awareness about the disease and emphasise the need for change in attitude.

This includes supporting World Pancreatic Cancer Day, which took place last week on November 13.

Markus Renschler, senior VP and global head of hematology and oncology medical affairs for Celgene, said: “Putting a dent in the rather grim pancreatic cancer statistics will be challenging, but with the appropriate treatment and the more than 170 global clinical trials evaluating investigational treatments in approximately 35,000 patients we believe outcomes will be improved for patients.”

Awareness was also lacking in other countries surveyed across Europe and the US. Respondents in Spain knew the least about pancreatic cancer, with 26% admitting to knowing almost nothing.

Across all countries, 61% of respondents ranked supporting ways to increase screening and earlier diagnosis as being among the most important goals in terms of raising awareness, followed by a call for more research to prevent pancreatic cancer (53%).

Ali Stunt, founder and CEO of Pancreatic Cancer Action: “Throughout the world, this type of cancer has been persistently underfunded and has languished in the 'too-hard-to-deal-with' category for far too long. This is reflected in the dire survival rates. More investment into both research and treatment is required to make the long overdue improvements in outcomes for patients.”

Article by
Kirstie Pickering

17th November 2014

From: Marketing

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
IGNIFI

We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...

Latest intelligence

PM Society Digital Awards – the power of together
Our chief executive, Emma Statham, writes about the value of awards and the power of together....
Seduction_feature_image_thumb.jpg
Seduce anyone in four simple steps
You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....

Infographics